Hepatoblastomas in Oman: Unveiling success

Area of Science:

• Pediatric Oncology
• Hepatobiliary Malignancies

Background:

• Primary malignant liver tumors are rare in children, with hepatoblastoma (HB) being the most common type.
• Limited literature exists on pediatric liver cancer in Arab populations.
• Oman's national referral center data provides a unique insight into HB epidemiology.

Purpose of the Study:

• To describe the Omani experience with hepatoblastoma (HB) over 21 years.
• To analyze clinical, radiological, and laboratory characteristics, treatments, and outcomes of pediatric HB in Oman.
• To address the rare incidence of HB in Arab populations.

Main Methods:

• Retrospective review of medical records of pediatric HB patients.
• Study conducted at the Royal Hospital, Muscat, Oman (1991-2012).
• Examination of clinical, radiological, laboratory data, treatments, and outcomes.

Main Results:

• Fifteen pediatric patients with HB were treated during the study period.
• Ten patients survived, with nine achieving remission and one in stable condition.
• A 91% survival rate was observed among patients who completed therapy; three patients did not survive, and two were lost to follow-up.

Conclusions:

• Hepatoblastoma (HB) demonstrates an excellent prognosis in the Omani pediatric population.
• Non-compliance with therapy is identified as the main barrier to improving patient outcomes.
• Further research on adherence to treatment protocols is warranted.